𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Oncogene amplifications in early-stage human prostate carcinomas

✍ Scribed by Alain Latil; Jean-Christophe Baron; Olivier Cussenot; Georges Fournier; Laurent Boccon-Gibod; Alain Le Duc; Rosette Lidereau


Publisher
John Wiley and Sons
Year
1994
Tongue
French
Weight
277 KB
Volume
59
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Genomic aberrations in early stage human
✍ Hisaki Nagai; Mathurose Ponglikitmongkol; Jiro Fujimoto; Hidenao Yamamoto; Yong πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 390 KB πŸ‘ 1 views

## Background: Primary liver cancer, which most often takes the form of hepatocellular carcinoma (hcc), is among the 10 most common cancers in humans worldwide. in hepatocarcinogenesis, evidence of a multistep process is supported by the marked increase of hcc incidence with age; most hccs are diag

Amplification of oncogenes in human canc
✍ Manfred Schwab πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 369 KB πŸ‘ 2 views

Gene amplification refers to a genomic change that results in an increased dosage of the gene(s) affected. Amplification represents one of the major molecular pathways through which the oncogenic potential of proto-oncogenes is activated during tumorigenesis. The architecture of amplified genomic st

Amplification of the c-myc proto-oncogen
✍ Dr. Vicki V. Baker; Kenneth D. Hatch; Hugh M. Shingleton πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 357 KB

Amplification without structural rearrangements of the c-myc proto-oncogene was found in 14 of 44 primary cervical neoplasms. There was no apparent correlation with stage of disease or degree of cellular differentiation. The prognostic significance of c-myc amplification cannot be determined from th

int-2 Oncogene amplification and prognos
✍ Laura Fioravanti; Vera Cappelletti; Danila Coradini; Patrizia Miodini; Giorgio B πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 101 KB πŸ‘ 1 views

The role of int-2 oncogene amplification on the prognosis of breast cancer patients was investigated in 128 patients with node-negative primary breast cancers given first-line local-regional treatments until relapse and with a median follow-up of 65 months. Tumours had been previously characterised